Cureus

Weight Loss and Diabetes Benefits of Drugs That Activate the GLP-1 Receptor

Updated

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are important for managing obesity and type 2 diabetes mellitus (T2DM).

  • GLP-1 RAs mimic the effects of the natural hormone GLP-1 to help regulate blood sugar levels and promote weight loss.
  • They may offer additional benefits for cardiovascular and kidney health.
  • Recent clinical studies suggest GLP-1 RAs could be effective for both diabetic and nondiabetic individuals.
  • The review highlights the need for further research to clarify the broader benefits of GLP-1 RAs.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free